Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Scholar Rock (NASDAQ: SRRK) has announced the granting of inducement equity awards to 19 newly hired employees. The awards consist of inducement stock options to purchase 89,515 shares of common stock and inducement restricted stock units covering 67,135 shares.
The awards are governed by the Company's 2022 Inducement Equity Plan and related agreements. The stock options have an exercise price of $28.93, matching the closing price on April 14, 2025. The vesting schedule includes 25% of shares vesting on the first employment anniversary, with the remaining 75% vesting in 12 quarterly installments. The restricted stock units will vest in four equal annual installments, contingent on continued employment.
Scholar Rock (NASDAQ: SRRK) ha annunciato la concessione di premi azionari di incentivazione a 19 nuovi dipendenti. I premi consistono in opzioni su azioni di incentivazione per l'acquisto di 89.515 azioni ordinarie e unità azionarie ristrette di incentivazione per un totale di 67.135 azioni.
I premi sono regolati dal Piano Azionario di Incentivazione 2022 della Società e dai relativi accordi. Le opzioni hanno un prezzo di esercizio di 28,93 $, corrispondente al prezzo di chiusura del 14 aprile 2025. Il piano di maturazione prevede il vesting del 25% delle azioni al primo anniversario di assunzione, mentre il restante 75% matura in 12 rate trimestrali. Le unità azionarie ristrette matureranno in quattro rate annuali uguali, subordinatamente alla permanenza in servizio.
Scholar Rock (NASDAQ: SRRK) ha anunciado la concesión de premios de capital por incentivo a 19 empleados recién contratados. Los premios consisten en opciones de acciones por incentivo para comprar 89,515 acciones ordinarias y unidades restringidas de acciones por incentivo que cubren 67,135 acciones.
Los premios están regulados por el Plan de Capital por Incentivo 2022 de la Compañía y los acuerdos relacionados. Las opciones de acciones tienen un precio de ejercicio de $28.93, que coincide con el precio de cierre del 14 de abril de 2025. El calendario de adquisición incluye que el 25% de las acciones se adquieren en el primer aniversario del empleo, y el 75% restante se adquiere en 12 cuotas trimestrales. Las unidades restringidas de acciones se adquirirán en cuatro cuotas anuales iguales, condicionadas a la continuidad en el empleo.
Scholar Rock (NASDAQ: SRRK)는 19명의 신입 직원에게 유인 주식 보상을 부여했다고 발표했습니다. 이 보상은 보통주 89,515주를 구매할 수 있는 유인 스톡 옵션과 67,135주에 해당하는 유인 제한 주식 단위로 구성됩니다.
보상은 회사의 2022년 유인 주식 계획 및 관련 계약에 따라 관리됩니다. 스톡 옵션의 행사가격은 28.93달러로 2025년 4월 14일 종가와 동일합니다. 베스팅 일정은 근무 첫 해 기념일에 25%가 베스팅되고, 나머지 75%는 12분기 분할로 베스팅됩니다. 제한 주식 단위는 계속 고용 조건 하에 4년간 매년 동일한 비율로 베스팅됩니다.
Scholar Rock (NASDAQ : SRRK) a annoncé l’attribution de primes d’actions incitatives à 19 nouveaux employés. Ces primes comprennent des options d’achat d’actions incitatives portant sur 89 515 actions ordinaires ainsi que des unités d’actions restreintes incitatives couvrant 67 135 actions.
Les primes sont régies par le Plan d’actions incitatives 2022 de la Société et les accords associés. Le prix d’exercice des options est de 28,93 $, correspondant au cours de clôture du 14 avril 2025. Le calendrier d’acquisition prévoit que 25 % des actions deviennent acquises à la première année d’emploi, les 75 % restants étant acquis en 12 versements trimestriels. Les unités d’actions restreintes seront acquises en quatre versements annuels égaux, sous réserve de la poursuite de l’emploi.
Scholar Rock (NASDAQ: SRRK) hat die Gewährung von Anreizaktien an 19 neu eingestellte Mitarbeiter bekannt gegeben. Die Auszeichnungen bestehen aus Anreiz-Optionsscheinen zum Kauf von 89.515 Aktien und Anreiz-Restricted-Stock-Units über 67.135 Aktien.
Die Auszeichnungen unterliegen dem Inducement Equity Plan 2022 des Unternehmens und den zugehörigen Vereinbarungen. Die Ausübungsoptionen haben einen Ausübungspreis von 28,93 $, entsprechend dem Schlusskurs vom 14. April 2025. Der Vesting-Zeitplan sieht vor, dass 25 % der Aktien am ersten Jahrestag der Beschäftigung vesten, die restlichen 75 % in 12 vierteljährlichen Raten. Die Restricted Stock Units vesten in vier gleichen jährlichen Raten, vorbehaltlich der fortgesetzten Beschäftigung.
- None.
- None.
The awards are subject to all terms and conditions and other provisions set forth in the Company’s 2022 Inducement Equity Plan (the “Plan”) and the award agreements thereunder.
The Plan, initially adopted by the Company’s board of directors on June 16, 2022, and as amended from time to time, is used exclusively for the grant of equity awards to individuals who were not previously employees of Scholar Rock, or following a bona fide period of non-employment, as an inducement material to such individuals entering into employment with Scholar Rock, pursuant to Nasdaq Listing Rule 5635(c)(4).
The inducement stock options have an exercise price of
About Scholar Rock
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily, the company is named for the visual resemblance of a scholar rock to protein structures. Over the past decade, Scholar Rock has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.
This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about our approach at ScholarRock.com and follow @ScholarRock and on LinkedIn.
Scholar Rock® is a registered trademark of Scholar Rock, Inc.
Availability of Other Information About Scholar Rock
Investors and others should note that we communicate with our investors and the public using our company website www.scholarrock.com, including, but not limited to, company disclosures, investor presentations and FAQs, Securities and Exchange Commission filings, press releases, public conference call transcripts and webcast transcripts, as well as on X (formerly known as Twitter) and LinkedIn. The information that we post on our website or on X (formerly known as Twitter) or LinkedIn could be deemed to be material information. As a result, we encourage investors, the media and others interested to review the information that we post there on a regular basis. The contents of our website or social media shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250418685302/en/
Scholar Rock:
Investors & Media
Rushmie Nofsinger
ir@scholarrock.com
media@scholarrock.com
857-259-5573
Source: Scholar Rock
FAQ
What equity awards did Scholar Rock (SRRK) grant to new employees in 2025?
How does the vesting schedule work for SRRK's 2025 inducement stock options?
What is the exercise price for Scholar Rock's April 2025 inducement stock options?
How are SRRK's 2025 inducement restricted stock units structured?
